| CMR | Cardiovascular magnetic resonance |
| CVD | Cardiovascular diseases |
| HF | Heart failure |
| EF | Ejection fraction |
| ECV | Extracellular volume |
| LGE | Late gadolinium enhancement |
| HFrEF | Heart failure with reduced EF |
| HFmrEF | Heart failure with mildly reduced EF |
| HFpEF | Heart failure with preserved EF |
| GLS | Global longitudinal strain |
| CRT | Cardiac resynchronization therapy |
| DCM | Dilated cardiomyopathy |
| SSFP | Steady-state free-precession |
| SCD | Sudden cardiac death |
| NT-proBNP | N-terminal pro B-type natriuretic peptide |
| HCM | Hypertrophic cardiomyopathy |
| ACM | Arrhythmogenic cardiomyopathy |
| ECG | Electrocardiography |
| RCM | Restrictive cardiomyopathy |
| CA | Cardiac amyloidosis |
| ATTR | Transthyretin amyloidosis |
| AL | Monoclonal immunoglobulin light-chain amyloidosis |
| LVNC | Left ventricular noncompaction |
| TS | Takotsubo syndrome |
| AFD | Anderson–Fabry disease |
| CT | Computed tomography |